A clinical study to compare two supplementary injection techniques using articaine in cases with symptomatic irreversible pulpitis.

Not Applicable

Conditions: Health Condition 1: K040- Pulpitis

Registration Number: CTRI/2020/04/024612

Lead Sponsor: Dr Harsh Jain

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Systemically healthy patients.

2. Patients 18â??65 years old.

3. Not allergic to articaine or epinephrine.

4. No facial paresthesia.

5. Not taking any analgesic drug 6 hours before treatment.

6. Not taking any medication that interferes with anesthesia, such as tricyclic antidepressants and beta-blockers.

7. The absence of pathogenesis in areas planned for injection.

8. Not pregnant.

9. The absence of pathologic periodontal pockets during probing.

10. Patients with a mandibular molar tooth exhibiting symptomatic irreversible pulpitis.

11. Vital coronal pulp on access opening.

12. American society of anesthesiologist class 1 medical history.

13. The ability to understand the use of pain scale.

14. Patient experiencing greater than moderate pain and spontaneous and prolonged response to cold testing with Endo-Ice will be included in the study.

15. Teeth showing normal periapical view in the radiograph.

Exclusion Criteria

1. A standard inferior alveolar nerve block injection will be performed using articaine 4% with epinephrine 1:100,000. Ten minutes after the injection, the patients will be asked about lip numbness. Patients without profound lip numbness will be excluded from the study because the block will be considered â??missedâ?? which will also be confirmed with electric pulp sensibility test.

2. Participants with periapical lesions, abscesses or cellulites at the relevant tooth, those with a medical treatment history or those having undergone root canal treatment for the relevant tooth will also be excluded from the study.